Tom Frohlich, Chief Operating Officer at CHINOOK THERAPEUTICS, INC. (KDNY), sold 3,735 shares at $12.74 ($48K) on 2022-02-11, disclosed to the SEC on 2022-02-14.
Open-market sale of $48k KDNY by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KDNY | SELL | 2023-02-02 | $225K | — | Filing → |
| KDNY | SELL | 2022-12-15 | $250K | — | Filing → |
| KDNY | SELL | 2022-11-09 | $222K | — | Filing → |